Detalhe da pesquisa
1.
Treatment of Upper Facial Lines With DaxibotulinumtoxinA for Injection: Results From an Open-Label Phase 2 Study.
Dermatol Surg
; 49(1): 60-65, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533798
2.
A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines: A Focus on Safety From the SAKURA 3 Study.
Dermatol Surg
; 47(1): 42-46, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32773447
3.
Botulinum toxin type E associated with reduced itch and pain during wound healing and acute scar formation following excision and linear repair on the forehead: A randomized controlled trial.
J Am Acad Dermatol
; 89(6): 1317-1319, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666427
4.
Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines.
Dermatol Surg
; 44(11): 1437-1448, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30096106
5.
The Potential Role of Botulinum Toxin in Improving Superficial Cutaneous Scarring: A Review.
J Drugs Dermatol
; 17(9): 956-958, 2018 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30235381
6.
Forehead Line Treatment With OnabotulinumtoxinA in Subjects With Forehead and Glabellar Facial Rhytids: A Phase 3 Study.
Dermatol Surg
; 43 Suppl 3: S274-S284, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33065953
7.
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial.
Neurology
; 102(4): e208091, 2024 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295339
8.
A technology evaluation of the atypical use of a CPP-containing peptide in the formulation and performance of a clinical botulinum toxin product.
Expert Opin Drug Deliv
; 20(9): 1157-1166, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37847051
9.
Safety and Efficacy of EB-001, a Novel Type E Botulinum Toxin, in Subjects with Glabellar Frown Lines: Results of a Phase 2, Randomized, Placebo-Controlled, Ascending-Dose Study.
Plast Reconstr Surg
; 142(6): 847e-855e, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30489516
10.
Viramidine, a prodrug of ribavirin, shows better liver-targeting properties and safety profiles than ribavirin in animals.
Antivir Chem Chemother
; 14(3): 145-52, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-14521331
11.
Remofovir mesylate: a prodrug of PMEA with improved liver-targeting and safety in rats and monkeys.
Antivir Chem Chemother
; 15(6): 307-17, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15646644
12.
Viramidine demonstrates better safety than ribavirin in monkeys but not rats.
Drug Chem Toxicol
; 27(3): 191-211, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15478943